News
News

The latest updates from AFAR.

Experts in the News: Barzilai, Kirkland, and Niedernhofer on Senescent “Zombie” cells, in Associated Press

May 20
2019

Experts in the News: Barzilai, Kirkland, and Niedernhofer on Senescent “Zombie” cells, in Associated Press

  On May 14, 2019, Associated Press featured AFAR experts Nir Barzilai, MD, James L. Kirkland, MD, PhD, and Laura Niedernhofer, MD, PhD, in an article on the role of senescent cells and aging. Dr. Barzilai is AFAR’s Deputy Scientific Director and a multiple grantee. Dr. Kirkland is AFAR’s President-Elect and a 2012 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient. Dr. Niedernhofer is received AFAR’s 2018 Vincent Cristofalo Rising Star Award in Aging Research. Read the article —"Zombie cells' buildup in your body may play role in aging”—here.  


View MoreREAD MORE


Grantees in the News: Patrick Hof and David Sinclair in The New Yorker, “Can we live longer but stay younger?”

May 15
2019

Grantees in the News: Patrick Hof and David Sinclair in The New Yorker, “Can we live longer but stay younger?”

On May 13, The New Yorker featured AFAR experts Patrick Hof, MD and David Sinclair, PhD in an article highlighting on-going and innovative research and tech solutions that will extend healthspan. Dr. Hoff is a 1996 AFAR Research Grant for Junior Faculty recipient. Dr. Sinclair is an AFAR board member, 2018 Irving S. Wright awardee, and a 2000 AFAR Research Grant for Junior Faculty recipient. Read the article—“Can we live longer but stay younger?”—here.  


View MoreREAD MORE


Grantee in the News: Reisa Sperling to lead two new Alzheimer’s trials, Yahoo Finance reports

May 15
2019

Grantee in the News: Reisa Sperling to lead two new Alzheimer’s trials, Yahoo Finance reports

On May 13, 2019, Yahoo Finance featured AFAR expert Reisa Sperling, MD in an article announcing that Dr. Sperling will lead a two new Alzheimer’s clinical trials. Dr. Sperling is a 2003 Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76) scholar. The investigational oral BACE (beta amyloid cleaving enzyme) inhibitor elenbecestat and the investigational anti-amyloid beta (Ab) protofibril antibody BAN2401, which are currently being evaluated as potential treatments for early Alzheimer's disease (AD), have been selected by the Alzheimer’s Clinical Trial Consortium (ACTC) as potential treatments to be evaluated in upcoming clinical studies targeting primary…


View MoreREAD MORE


Grantee in the News: Joe Verghese in NY Times on social dancing and delaying dementia

May 6
2019

Grantee in the News: Joe Verghese in NY Times on social dancing and delaying dementia

On April 30th 2019, The New York Times featured insights from AFAR expert Joe Verghese, MBBS in an article about the long term health benefits of dance. The article references a study led by Verghese’s team, which found that social dancing may decrease the risk of developing dementia. Dr. Verghese is a 2004 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar. Read “Is Dancing the Kale of Exercise?” here.


View MoreREAD MORE


Grantee in the News: Ana Maria Cuervo elected to National Academy of Sciences

May 6
2019

Grantee in the News: Ana Maria Cuervo elected to National Academy of Sciences

AFAR congratulates Ana Maria Cuervo, MD, PhD on her election into the esteemed National Academy of Sciences. Dr. Cuervo is a 2008 Vincent Cristofalo Rising Star Award in Aging Research recipient and 2000 Glenn Foundation for Medical Research and AFAR Grant for Junior Faculty recipient. She also serves as Co-Director of the Nathan Shock Center of Excellence in the Basic Biology of Aging at Albert Einstein College of Medicine, for which AFAR serves as the Coordinating Center. A private, nonprofit institution established in 1863, the National Academy of Sciences elected 100 new members and 25 foreign associates this year “in recognition of their distinguished…


View MoreREAD MORE




BACK TO TOPBACK TO TOP